Selenium element is considered as one of the most important micronutrients for many biological systems. It has been well demonstrated that Se nanoparticles (Se NPs) express greater bioavailability, biocompatability, and less toxicity than that of Se in ion form. In this work, the Se NPs were facilely fabricated by a one-step plasma process in the ethanol–water solution mixture. The as-prepared Se NPs were well characterized by scanning electron microscopy (SEM), X-ray diffraction (XRD), UV-vis spectroscopy, Raman spectroscopy, and energy dispersive X-ray spectroscopy (EDX). The prepared Se NPs were a light red color with a spherical shape and particle size in the range of 100–200 nm. The average diameter of the Se NPs calculated from the ImageJ software and TEM image was approximately 154 nm. The EDX results showed that the Se NPs prepared by the plasma process in the solution were highly pure and stable. The acute oral toxicity of the obtained Se NPs toward mice was also studied, which revealed that the Se NPs were safe for the human body. The mechanism for the formation of Se NPs from the Se ions under the solution plasma condition was also studied and discussed.

Background: Hepatocellular carcinoma (HCC) is a leading cancer with very high incidence and mortality and low survival rate in Vietnam and worldwide. This study aimed to investigate the survival outcome and its prognostic factors among HCC patients. Methods: This is a retrospective descriptive study on patients newly diagnosed with HCC at Hanoi Oncology Hospital, Vietnam from January 2018 to December 2020. Overall survival (OS) was calculated by the Kaplan-Meier method. Log-rank test and Cox regression were used to investigate the association among patients’ OS and their diagnosis and treatment factors. Results: A total of 674 patients were included. The median OS was 10.0 months. The survival rates at 6, 12, 24, and 36 months were 57.3%, 46.6%, 34.8%, and 29.7%, respectively. The initial performance status (PS), Child-Pugh score, and Barcelona Clinic Liver Cancer (BCLC) stage at the time of diagnosis are prognostic factors of HCC OS. A total of 451 (66.8%) patients have died, most of them (375 equally 83.1%) died at home, and only 76 (16.9%) died at hospital. Hepatocellular carcinoma patients living in the rural area more likely died at home than those living in the urban area (85.9% vs 74.8%, P = .007). Conclusions: Hepatocellular carcinoma has a poor prognosis with low OS. Performance status, Child-Pugh score, and BCLC stage were the independent prognostic factors for the survival outcome of HCC patients. The fact that most HCC patients died at home suggested that home-based hospice care needs to be paid special attention.

The villous height to crypt depth (V:C) ratio is one of the most significant parameters which is associated with the nutrients’ absorption and greater body weight. The objective of this study was to assess the relationship between V:C ratio, gut bacteria counts and production parameters in broiler chickens. A total of 100 individual broilers were randomly selected from a farm with 40,000 Ross 308 chickens and slaughtered for sampling at three different ages including 14, 28 and 37 day old. Villous height and crypt depth were measured for each section of the small intestine to calculate V:C ratio. Intestinal score and gut microbiology including total coliforms, lactic acid bacteria and Salmonella prevalence were assessed. At day 37, besides those parameters, the carcass, breast, legs and wings were taken for weight measurements. Leg and breast color was also measured. Data were statistically analyzed by STATA software to explore the relationship between V:C and those parameters. The results showed the positive correlation between V:C of duodenum and the number of lactic acid bacteria at 28 days of age (P < 0.05). Moreover, the leg yield was negatively related to the V:C ratio of jejunum (P < 0.05). No significant correlations were found between V:C ratio and other parameters. The results indicated the potential of controlling V:C ratio to improve gut health and meat quality of broiler chickens and thus, further studies should be conducted to fully evaluate these correlations.

No abstract

Objective To evaluate the clinical outcomes following first-line treatment with sorafenib in patients with primary hepatocellular carcinoma (HCC). Methods This retrospective cohort study enrolled patients with primary HCC that had been treated with sorafenib. Their data were collected from the hospital medical records database at three time-points: after three cycles, after six cycles and at the end of the sorafenib treatment regimen. The starting dose was 800 mg/day sorafenib but this could be reduced to 600 mg/day or 400 mg/day if patients developed adverse events (AEs). Results A total of 98 patients participated in the study. Of these, nine (9.2%) had a partial response, 47 patients (48.0%) had stable disease and 42 patients (42.9%) had progressive disease. The overall disease control rate was 57.1% (56 of 98 patients). Median progression-free survival for the overall cohort was 4.7 months. The most common AEs were hand-foot skin reaction (49 of 98 patients; 50.0%), fatigue (41 of 98 patients; 41.8%), appetite loss (39 of 98 patients; 39.8%) and hepatotoxicity/transaminitis (24 of 98 patients; 24.5%). The majority of the AEs were toxicity grades 1 and 2. Conclusion Sorafenib as a first-line treatment for primary HCC patients provided survival benefits and the AEs were well tolerated by patients.